My biotech portfolio is up OVER %5 today. EPCT is at zero change on negligible volume. If that isn't a glaring example of a lack of faith and good standing in the marketplace, I do not know what is.These goons need to go else this company is headed to the pink sheets.
The article blurb is nothing. The link is for a blog that merely mentions a weekly update by R&R.Because that article blurb is new doesnt make the rating new.When a research firm initiates coverage they issue a performance rating and for their clients they will issue periodic reviews of the companies they cover usually broken down by sector and analyst.So any even though the review mentions EPCT it is only because of an event. Its not new coverage or a new rating.All in all, its not a big deal, just a blurb.
[...]These goons need to go else[...]Telling that for months (maybe years)Wannabe amateur noname management - no reputation, no experience, no standing, no nothing.And as bonus we got smeary Savage Soprano.They have to business development, they have no business strategy, they have no plan at allVote these bastards out and find an adeaquate replacment.
So how do you really feel?I thought I saw something today on my blackberry about an upgrade to a market outperform............but I CAN'T find it anywhere else!
:-) Thought those posting was aimed for Stockman58.